ProShare Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-20,973
Closed -$806K 1892
2023
Q2
$806K Buy
20,973
+10,441
+99% +$401K ﹤0.01% 774
2023
Q1
$244K Sell
10,532
-1,279
-11% -$29.6K ﹤0.01% 1327
2022
Q4
$309K Buy
11,811
+1,023
+9% +$26.8K ﹤0.01% 1225
2022
Q3
$211K Buy
+10,788
New +$211K ﹤0.01% 1375
2022
Q2
Sell
-13,041
Closed -$214K 2225
2022
Q1
$214K Sell
13,041
-2,940
-18% -$48.2K ﹤0.01% 1849
2021
Q4
$260K Buy
15,981
+2,169
+16% +$35.3K ﹤0.01% 1874
2021
Q3
$176K Sell
13,812
-2,363
-15% -$30.1K ﹤0.01% 1818
2021
Q2
$228K Buy
+16,175
New +$228K ﹤0.01% 2068
2019
Q4
Sell
-5,831
Closed -$31K 1810
2019
Q3
$31K Sell
5,831
-201
-3% -$1.07K ﹤0.01% 1630
2019
Q2
$46K Sell
6,032
-779
-11% -$5.94K ﹤0.01% 1578
2019
Q1
$136K Buy
6,811
+76
+1% +$1.52K ﹤0.01% 1536
2018
Q4
$89K Sell
6,735
-1,283
-16% -$17K ﹤0.01% 1485
2018
Q3
$295K Sell
8,018
-289
-3% -$10.6K ﹤0.01% 1368
2018
Q2
$291K Buy
8,307
+8
+0.1% +$280 ﹤0.01% 1402
2018
Q1
$386K Sell
8,299
-1,367
-14% -$63.6K ﹤0.01% 1207
2017
Q4
$362K Buy
9,666
+664
+7% +$24.9K ﹤0.01% 1287
2017
Q3
$479K Buy
9,002
+1,105
+14% +$58.8K ﹤0.01% 978
2017
Q2
$450K Sell
7,897
-91
-1% -$5.19K ﹤0.01% 994
2017
Q1
$429K Sell
7,988
-2,028
-20% -$109K ﹤0.01% 1067
2016
Q4
$571K Buy
10,016
+1,148
+13% +$65.4K 0.01% 1016
2016
Q3
$551K Sell
8,868
-1,619
-15% -$101K 0.01% 917
2016
Q2
$593K Buy
10,487
+923
+10% +$52.2K 0.01% 894
2016
Q1
$613K Sell
9,564
-695
-7% -$44.5K 0.01% 908
2015
Q4
$1.44M Buy
+10,259
New +$1.44M 0.02% 612